Luc Tanguay
Geen lopende functies
Profiel
Luc Tanguay served as the President, CEO & Non-Independent Director of Theratechnologies, Inc. from 2012 to 2020.
Prior to that, he was a Director at Ambrilia Biopharma, Inc. from 2006 to 2010.
He also served as the Chairman of Valeo Management LP.
Tanguay received his undergraduate and graduate degrees from the University of Sherbrooke.
Eerdere bekende functies van Luc Tanguay
| Bedrijven | Functie | Einde |
|---|---|---|
| THERATECHNOLOGIES INC. | Algemeen Directeur | 06-04-2020 |
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Directeur/Bestuurslid | 31-03-2010 |
Valeo Management LP
 Valeo Management LP Miscellaneous Commercial ServicesCommercial Services Valeo Management LP offers research commercialization services. The firm provides Life sciences and biotechnologies, engineering, information and communications technologies services. The company was founded in 2000 and is headquartered in Montreal, Canada. | Voorzitter | - |
Opleiding van Luc Tanguay
| University of Sherbrooke | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| THERATECHNOLOGIES INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Health Technology |
Valeo Management LP
Valeo Management LP Miscellaneous Commercial ServicesCommercial Services Valeo Management LP offers research commercialization services. The firm provides Life sciences and biotechnologies, engineering, information and communications technologies services. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |